Kenichi Akamatsu

SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe.

NapaJen Pharma, Inc. develops drug delivery technology solutions through cellular transport pathways. Its products include lead platform and drug delivery. The firm specializes in the development of novel drug delivery systems by utilizing natural transport pathways whose cells are used to move molecular cargo into themselves and across internal compartments. The company was founded by Dr. Kazuo Sakurai and Hironori Ando in December 2004 and is headquartered in Burlingame, CA.

The Innovation Network Corporation of Japan (INCJ), a unique public-private partnership aimed at promoting innovation and enhancing the value of businesses in Japan, was launched in July 2009. Leveraging the rich history of Japanese technological prowess, the INCJ aims to provide financial, technological and management support in order to promote the creation of next-generation businesses through 'open innovation,' or the flow of technology and expertise beyond the boundaries of existing organizational structures. The INCJ will draw on funding as well as management and technological expertise from the public and private sectors. The INCJ is actively reviewing various investment opportunities in areas of environment and energy, electronics and IT, bio-tech, and infrastructure such as water supply, railway service, and nuclear power supply. Each investment will be thoroughly vetted to ensure it meets the exacting standards of the INCJ's Innovation Network Committee, which will make the final investment decisions. The INCJ is capitalized at 92 billion yen, with the Japanese government injecting 82 billion yen and 19 private corporations (refer to details in Appendix below) providing a further 10 billion yen. The government will also provide guarantees up to a total of 800 billion yen for INCJ investments, giving it an investment capability of approximately 900 billion yen (US$10 billion). The INCJ will be established for a period of 15 years.

KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC.

Atonarp, Inc. provides chemical analysis solutions and systems. The firm develops the Smart Spectrometer technology that focus on industrial gas process analytics applications in the energy, pharmaceutical, petrochemical and semiconductor industries. The company was founded by Tomoyoshi Sato and Prakash S. Murthy in November 2009 and is headquartered in Minato-Ku, Japan.

The Iyo Bank Ltd. engages in the provision of banking and leasing services. It operates through the following segments: Banking, Leasing, and Others. The Banking segment offers banking services such as deposits, loans, securities investments, and foreign exchange. The Leasing segment handles leasing business through its subsidiary. The Others segment includes information processing contract, software development, and securities businesses. The company was founded on March 15, 1878 and is headquartered in Matsuyama, Japan.

Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan.

JFE Shoji Corp. engages in the import, export, and domestic and foreign trade of steel products and steel raw materials. It provides iron ores, coals, ferrous alloys, steel scraps, steel plates, and steel pipes. It also deals with ship, food, and electronics businesses. The company was founded on January 5, 1954 and is headquartered in Tokyo, Japan.

INPEX Idemitsu Norge AS engages in exploration, development and production of crude oil and natural gas. The company was founded on September 25, 1989 and is headquartered in Oslo, Norway.

PRISM Pharma Co., Ltd. operates as a pharmaceutical company that focuses on discovery and development of small molecules to modulate protein-protein interactions. It utilizes protein secondary structure mimetic library, which modulates intracellular protein and protein interactions. The firm develops an anti-cancer drug CP/Catenin inhibitor PRI-724 that acts on both cancer cells and cancer stem cells that can switch from proliferation to differentiation. The company was founded by Hiroyuki Kouji on November 2, 2006 and is headquartered in Fujisawa, Japan.

Part of Eli Lilly & Co., Eli Lilly Japan KK is a Japanese company that manufactures and trades pharmaceutical products. The company is based in Kobe, Japan.

Part of Senshu Ikeda Holdings, Inc., The Senshu Ikeda Bank Ltd. is a commercial bank based in Osaka, Japan. The Senshu Ikeda Bank provides commercial banking services. The Japanese company was founded in 1951. Atsushi Ukawa has been the CEO of the company since 1980.

Senshu Ikeda Investment Management Co. Ltd. (Senshu Ikeda) is an investment management firm headquartered in Osaka, Japan. The firm was founded in 1987 and is a subsidiary of The Senshu Ikeda Bank Ltd., which is owned by Senshu Ikeda Holdings, Inc. (TYO: 8714). Senshu Ikeda provides investment management services to Japanese investors.

Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan.

Morishita Co., Ltd. is engaged in the planning, development, import, manufacture and sales of pillows, cushions, rattan products, covers, other beddings and interior products. The company was founded in October 1953 and is headquartered in Osaka, Japan.

Japan Medical Information Research Institute, Inc. engages in the collection, analysis, marketing, and consulting of medical information. The company was founded on July 14, 2005 and is headquartered in Tokyo, Japan.

Part of Bayer AG, Monsanto Japan Ltd. is a Japanese company that manufactures a wide range of genetically altered seeds, fertilizers, and agrochemicals. The company is based in Tokyo, Japan.

Fast Track Initiative, Inc. (FTI) is a Venture Capital firm, a subsidiary of Life Science Management, Inc. founded in 2004 by Koichi Ashida and Hiromichi Kimura. Fast Track Initiative, Inc. is headquartered in Tokyo with additional office in the Unites States.